Numinus Wellness Aktie

Numinus Wellness Inc. (NUMI.V) TSXV - TSXV Echtzeitpreis. Währung in CAD 1,83+0,28 (+18,0645 %) Ab 10:52AM EST. Markt geöffnet.

1,70+0,15 (+9,6774 %) Ab 10:01AM EST. Markt geöffnet.

Dec. 27, 2020 1:07 PM ETNuminus Wellness Inc. (LKYSF)3 Comments2 Likes Summary The Canadian government continues to make moves in favour of psychedelics. Diagnosis rates of depression and anxiety are higher than ever, pathing a way for psychedelics to become a legit alternative treatment option. Numinus will benefit from changing consumer views about psychedelics. The company has a first-mover advantage because of its ketamine-enabled clinics and strong research team. Numinus (OTC:OTCPK:LKYSF) is a Canadian company that aims to address the global mental health crisis by producing and delivering psychedelic-assisted therapy solutions. The company has three potential main revenue segments, with the most interesting one being ‘Numinus Clinics’, where everyday consumers can get access to psychedelics in order to treat mental and emotional traumas. There is no doubt that the governments around the world are changing their sentiment towards drugs that were previously perceived as solely harmful. The Canadian government specifically has made many moves in the past year in favour of psychedelics, and we believe that Numinus will be one of the first companies to benefit from not only a psychedelics craze but also an investor craze for high-growth companies. The company launched on the Canadian Ventures stock market in May 2020 and has raised close to $20 million in the past year alone. The company’s stock price saw a huge spike at the end of 2020 partly due to the acquisition of three relevant Montreal clinics as well as the completion of the first extraction of psilocybe mushrooms. We possess a long-term bullish view of the company simply due to the opportunity for Numinus to capitalize on a therapy that could become mainstream. Consumer views will continue to become more positive towards psychedelics, and the Canadian government is actively supporting research.